TWST

Twist Bioscience Corporation

TWST · CIK 1581280 · Annual (10-K) · Last 7 years

Financial Trends

Revenue
20192025
Net Income−$78M
20192025
Operating CF−$48M
20192025
Free Cash Flow−$76M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue———————
Cost of Revenue$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B
Gross Profit———————
R&D Expense$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
SG&A Expense$0.2B$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B
Operating Income$-0.1B$-0.2B$-0.2B$-0.2B$-0.2B$-0.1B$-0.1B
Net Income$-0.1B$-0.2B$-0.2B$-0.2B$-0.2B$-0.1B$-0.1B
EPS (Basic)$-1.30$-3.60$-3.60$-4.04———
EPS (Diluted)$-1.30$-3.60$-3.60$-4.04———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.6B$0.6B$0.8B$1.0B$0.7B$0.4B$0.2B
Current Assets$0.3B$0.3B$0.4B$0.6B$0.5B$0.3B$0.2B
Cash & Equivalents$0.2B$0.2B$0.3B$0.4B$0.5B$0.1B$0.0B
Total Liabilities$0.2B$0.1B$0.2B$0.2B$0.1B$0.1B$0.0B
Current Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Stockholders' Equity$0.5B$0.5B$0.6B$0.8B$0.6B$0.3B$0.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
Investing Cash Flow$-0.0B$-0.0B$0.1B$-0.2B$0.2B$-0.1B$-0.1B
Capital Expenditures$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.3B$0.3B$0.3B$0.2B
← Companies